Saha Ritubrita, Lo Mahadeb, De Papiya, Deb Alok K, Indwar Pallavi, Miyoshi Shin-Ichi, Kitahara Kei, Oka Tomoichiro, Dutta Shanta, Chawla-Sarkar Mamta
ICMR- National Institute for Research in Bacterial Infections (formerly ICMR-NICED), Kolkata, India.
Collaborative Research Center of Okayama University for Infectious Diseases in India, ICMR- National Institute for Research in Bacterial Infections (formerly ICMR-NICED), Kolkata, India; Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan; Research Center for Intestinal Health Science, Okayama University, Okayama, Japan.
Vaccine. 2025 Jan 25;45:126637. doi: 10.1016/j.vaccine.2024.126637. Epub 2024 Dec 27.
Despite global rotavirus vaccination efforts, rotavirus remains a leading cause of childhood deaths from acute gastroenteritis. Post-vaccination studies in India, particularly in eastern India, have been limited, despite high prevalence of rotavirus in this region prior to vaccine introduction. This study was conducted to assess the impact of rotavirus vaccine on the epidemiology of rotavirus and other enteric viruses, as well as the changes in the diversity of rotavirus strains among children (≤5 years) with acute gastroenteritis.
A total of 877 stool samples from children hospitalized with acute diarrhea during 2022-2023, were screened for enteric viruses using multiplex PCR. Rotavirus positive samples were genotyped by sequencing and phylogenetic analysis of VP4 and VP7 genes were done.
Out of 877 diarrheal cases, 47 % tested positive for at least one enteropathogenic virus. Rotavirus was most prevalent (25.9 %), followed by norovirus (11.4 %), adenovirus-F (10.6 %), and astrovirus (5.3 %). Among mixed infections, rotavirus and norovirus co-infections were the most common. Rotavirus infection was highest in children aged 12-24 months, while other enteric viruses were more common in the 6-24 month age group. Clinical severity was higher among rotavirus-infected patients compared to those infected with other enteric viruses. The G3P[8] genotype of rotavirus predominated, with notable increase in G2P[4] and the detection of rare strains like G3P[6] and G11P[25]. G3P[6] was identified for the first time in this region showing Wa-like genome constellation. Unlike pre-vaccine period, G9 genotype was not detected. Mutations in antigenic epitope of circulating strains compared to vaccine strains may affect vaccine efficacy.
The study highlights the persistent burden of childhood diarrhea despite rotavirus vaccination. Subtle alterations in the proportion of other enteric viruses and diversity of circulating rotavirus genotypes in the post-vaccination period were observed. Continuous long-term surveillance is required to evaluate the impact of vaccine in this region.
尽管全球开展了轮状病毒疫苗接种工作,但轮状病毒仍是儿童急性胃肠炎死亡的主要原因。在印度,尤其是印度东部,疫苗接种后的研究一直很有限,尽管在引入疫苗之前该地区轮状病毒的流行率很高。本研究旨在评估轮状病毒疫苗对轮状病毒和其他肠道病毒流行病学的影响,以及急性胃肠炎儿童(≤5岁)中轮状病毒株多样性的变化。
对2022 - 2023年因急性腹泻住院的儿童的877份粪便样本,使用多重PCR进行肠道病毒筛查。对轮状病毒阳性样本进行基因分型,通过对VP4和VP7基因进行测序和系统发育分析。
在877例腹泻病例中,47%至少一种肠道致病病毒检测呈阳性。轮状病毒最为常见(25.9%),其次是诺如病毒(11.4%)、腺病毒F(10.6%)和星状病毒(5.3%)。在混合感染中,轮状病毒和诺如病毒共同感染最为常见。12 - 24个月大的儿童轮状病毒感染率最高,而其他肠道病毒在6 - 24个月年龄组中更为常见。与感染其他肠道病毒的患者相比,轮状病毒感染患者的临床严重程度更高。轮状病毒的G3P[8]基因型占主导地位,G2P[4]显著增加,并且检测到了罕见毒株如G3P[6]和G11P[25]。G3P[6]在该地区首次被鉴定出具有类似Wa的基因组组合。与疫苗接种前时期不同,未检测到G9基因型。与疫苗株相比,循环毒株抗原表位的突变可能会影响疫苗效力。
该研究强调了尽管接种了轮状病毒疫苗,但儿童腹泻负担仍然持续存在。在疫苗接种后时期,观察到其他肠道病毒比例的细微变化以及循环轮状病毒基因型的多样性。需要持续进行长期监测以评估该地区疫苗的影响。